doomed

Is the HIF-PHI class of next-generation kidney drugs doomed in the U.S.?
Health

Is the HIF-PHI class of next-generation kidney drugs doomed in the U.S.?

The FDA’s current full response letter (CRL) for vadadustat — an oral remedy evaluated for the therapy of anemia in…
Back to top button
close